We already paid for these vaccines once

Source: Reshma Ramachandran & Zoey Thill, The Nation (Paid Registration)

To be sure, we should all celebrate the technologies that will hasten the end of this devastating disease. But thanking the manufacturers of the available vaccines—or even using their names as primary product descriptors—contributes to a narrative that elevates the value of private corporations while simultaneously minimizing the significant public investment in these vaccines. Meanwhile, pharmaceutical companies maintain an extractive relationship with taxpayers: We fund the discovery, and often the development, of novel treatments and vaccines—before handing them off to corporations to bring them to market. Then, we pay again to access them.

Over and over again, pharmaceutical companies have their product development de-risked by taxpayers, while reaping exorbitant profits with no obligation to ensure access to their products.

Read Full Article: We already paid for these vaccines once




Quick Menu

Facebook FTwitter T